Glenmark Pharmaceuticals Ltd.

About Glenmark Pharmaceuticals Ltd: Board of Directors: Executive Directors:

Mr. Glenn Saldanha Chairman and Managing Director

He joined Glenmark Pharmaceuticals Ltd. in 1998 as a director and in 2001 took over as
Managing Director and CEO of the company. So he has been the Managing Director of

the company for over 14 years.

Mr. Rajesh Desai Executive Director
He is the CFO of Glenmark Pharmaceuticals. He is working with Glenmark

Pharmaceuticals from past 30 years.

Mrs. Cheryl Pinto Director Corporate Affairs
She is working as an executive director from 1999 in Glenmark Pharmaceuticals. So she
is an executive director from past 16 years. She is also a promoter of the company and
holding around 0.29 percent shares.

Non-Executive Directors: 1. Mrs. B. E. Saldanha 23 years of experience with Glenmark

She is a part of promoter group of Glenmark Pharmaceuticals which holds more than 45
percent of the shares of company.
2. Mr. Hocine Sidi Said Founder and Director, Bio-nAbler
3. Mr. Bernard Munos Founder of InnoThink Center for Research in Biomedical
Innovation
4. Mr. N. B. Desai Founder of Equitorial Bank PLC, UK and Ex-Chairman Bank of
Baroda Uganda Ltd.
5. Dr. Brian W. Tempest Fellow Royal Society of Chemistry and Royal Society of
Medicine
6. Mr. J. F. Ribeiro Ex-Commissioner of Police, Mumbai
7. Mr. Sridhar Gorthi Partner at Trilegal
8. Mr. D. R. Mehta Ex-Deputy Governor, RBI and Ex-Chairman, SEBI

Key Management Personnel

Mrs. B.E. Saldanha (Non-Executive Director)

Mr. Glenn Saldanha (Chairman & Managing Director)
Mrs. Cherylann Pinto (Executive Director)
Mr. Rajesh Desai (Executive Director)

Mrs. B.E. Saldanha is key management personnel and also a Non-Executive Director

Shareholders Details: 1. Saldanha Family Trust: Saldanha Family Trust owns 45.45 percent of the shares of the
company. It is a privately held company whose headquarters are in India. (1)
2. Aranda Investments PTE Ltd: Aranda Investments PTE Ltd owns 3.99 percent of the
shares. It is a Mauritius-based foreign portfolio investor and wholly-owned indirect
subsidiary of Temasek Holdings Pvt. Ltd which is an investment company owned by the
Government of Singapore. (2)
3. Oppenheimer Funds Inc.: Oppenheimer Funds Inc. holds 2.48 percent of shares through
multiple portfolios and 2.44 percent of shares through Oppenheimer Developing Markets
Fund. It is a New York based investment manager. It operates as a subsidiary of
Oppenheimer Acquisition Corp which eventually is a subsidiary of MassMutual Holding,
LLC that ultimately linked to Massachusetts Mutual Life Insurance Company which is a
Fortune 500 company. (3)
4. Life Insurance Corporation of India: LIC holds 2.23 percent of shares of Glenmark.
5. HSBC: HSBC which is a British multinational bank headquartered in London owns 1.53
percent of the shares of Glenmark. HSBC also owns 1.53 percent of shares through
HSBC Investment Funds, Luxembourg which is a subsidiary of HSBC Global Asset
Management (UK) which comes under HSBC. HSBC owns 1.5 percent of shares through
HSBC GIF Mauritius Ltd. which is a subsidiary of HSBC Asset Management (India) Pvt.
Ltd. which operates under its UK division and ultimately comes under HSBC. (4) So
overall HSBC owns 4.56 percent shares of Glenmark Pharmaceuticals.
6. T Rowe Price Associates

1. (n.d.). Privco.com/Saldanha Family Trust. Retrieved september 28, 2015, from

Privo.com: http://www.privco.com/private-company/saldanha-family-trust
2. (n.d.). Retrieved from https://en.wikipedia.org/wiki/Temasek_Holdings
3. (n.d.). Retrieved 10 2, 2015, from
https://en.wikipedia.org/wiki/Massachusetts_Mutual_Life_Insurance_Company
4. (n.d.). Retrieved 10 2, 2015, from
http://www.bloomberg.com/research/stocks/private/snapshot.asp?
privcapId=22345899